Dr Reddy’s reports muted Q1FY27 results, net profit drops 69%
Dr Reddy’s reports muted Q1FY27 results, net profit drops 69%
High impactShort-term
You are viewing a historical snapshot of India (NSE / BSE). These figures are a preview to show what TradeTidings covers. Live, continuously updated India sentiment and stock impact is a Pro feature.
Get live India data with ProPharmaceuticals
-1.00Negative7 stories · last 90 days
Net news sentiment -1.00 (Negative) across 7 stories · last 90 days. Not a price prediction.
What's driving Pharmaceuticals now
Over the last 90 days, Pharmaceuticals shows 0 positive, 0 neutral and 7 negative news signals across its constituents. The auto-generated sector insight (top drivers with direction + rationale) appears here once the analysis worker has processed enough items.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Sentiment timeline
How news sentiment on the Pharmaceuticals sector has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
Not enough day-by-day history for the Pharmaceuticals sector yet. It builds as news is analysed — try the Week or Month view.
Constituent stocks
APOLLOHOSP
Apollo Hospitals Enterprise Ltd.
PharmaceuticalsNo coverage yet
CIPLA
Cipla Ltd.
0 · 0 · 22 stories
DRREDDY
Dr. Reddy's Laboratories Ltd.
0 · 0 · 33 stories
MAXHEALTH
Max Healthcare Institute Ltd.
PharmaceuticalsNo coverage yet
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
0 · 0 · 11 story
ABBOTINDIA
Abbott India Ltd.
PharmaceuticalsNo coverage yet
AJANTPHARM
Ajanta Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
ALIVUS
Glenmark Life Sciences Ltd. REBRANDED AS ALIVUS
PharmaceuticalsNo coverage yet
ALKEM
Alkem Laboratories Ltd.
PharmaceuticalsNo coverage yet
APLLTD
Alembic Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
ASTERDM
Aster DM Healthcare Ltd.
PharmaceuticalsNo coverage yet
ASTRAZEN
AstraZenca Pharma India Ltd.
PharmaceuticalsNo coverage yet
AUROPHARMA
Aurobindo Pharma Ltd.
PharmaceuticalsNo coverage yet
BIOCON
Biocon Ltd.
PharmaceuticalsNo coverage yet
CAPLIPOINT
Caplin Point Laboratories Ltd.
PharmaceuticalsNo coverage yet
CONCORDBIO
Concord Biotech Ltd.
PharmaceuticalsNo coverage yet
DIVISLAB
Divi's Laboratories Ltd.
PharmaceuticalsNo coverage yet
ERIS
Eris Lifesciences Ltd.
PharmaceuticalsNo coverage yet
FDC
FDC Ltd.
PharmaceuticalsNo coverage yet
FORTIS
Fortis Healthcare Ltd.
PharmaceuticalsNo coverage yet
GLAND
Gland Pharma Ltd.
PharmaceuticalsNo coverage yet
GLAXO
Glaxosmithkline Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
GLENMARK
Glenmark Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
GRANULES
Granules India Ltd.
PharmaceuticalsNo coverage yet
IPCALAB
Ipca Laboratories Ltd.
PharmaceuticalsNo coverage yet
JBCHEPHARM
J.B. Chemicals & Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
JUBLPHARMA
Jubilant Pharmova Ltd.
PharmaceuticalsNo coverage yet
KIMS
Krishna Institute of Medical Sciences Ltd.
PharmaceuticalsNo coverage yet
LALPATHLAB
Dr. Lal Path Labs Ltd.
PharmaceuticalsNo coverage yet
LAURUSLABS
Laurus Labs Ltd.
PharmaceuticalsNo coverage yet
LUPIN
Lupin Ltd.
0 · 0 · 11 story
MANKIND
Mankind Pharma Ltd.
PharmaceuticalsNo coverage yet
MEDANTA
Global Health Ltd.
PharmaceuticalsNo coverage yet
METROPOLIS
Metropolis Healthcare Ltd.
PharmaceuticalsNo coverage yet
NATCOPHARM
NATCO Pharma Ltd.
PharmaceuticalsNo coverage yet
NH
Narayana Hrudayalaya Ltd.
PharmaceuticalsNo coverage yet
POLYMED
Poly Medicure Ltd.
PharmaceuticalsNo coverage yet
PPLPHARMA
Piramal Pharma Ltd.
PharmaceuticalsNo coverage yet
RAINBOW
Rainbow Childrens Medicare Ltd.
PharmaceuticalsNo coverage yet
SANOFI
Sanofi India Ltd.
PharmaceuticalsNo coverage yet
SPARC
Sun Pharma Advanced Research Company Ltd.
PharmaceuticalsNo coverage yet
SUVENPHAR
Suven Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
SYNGENE
Syngene International Ltd.
PharmaceuticalsNo coverage yet
TORNTPHARM
Torrent Pharmaceuticals Ltd.
PharmaceuticalsNo coverage yet
VIJAYA
Vijaya Diagnostic Centre Ltd.
PharmaceuticalsNo coverage yet
ZYDUSLIFE
Zydus Lifesciences Ltd.
PharmaceuticalsNo coverage yet
Latest Tidings
The most recent stories affecting Pharmaceuticals, across all of our coverage.
Dr. Reddy's Q1 PAT Plunges 69%; US Generics Pricing Weighs Heavy
Dr. Reddy's reported a 69% year-on-year PAT decline in Q1 FY27, driven by a steep fall in US generics revenue. The sharp miss signals mounting pressure on India's pharma exporters from global pricing erosion.
High impactLong-term
Cipla Profit Dips in FY26 as Pharma Sector Faces Headwinds
Cipla's profit declined in FY26, pressuring its share price by 2% and raising questions about the company's earnings trajectory amid sector-wide challenges.
Medium impactLong-term
Nifty Pharma Index Falls Nearly 2% on Trump Tariff Plan for Generic Drugs
The Nifty Pharma index declined nearly 2% as investors reacted to Trump's announcement of a 200% tariff on generic drugs. Cipla and Dr Reddy's were among the top losers, with both stocks pressured by concerns over US revenue impact.
Medium impactLong-term
India-EU Trade Pact Nears Completion; Export-Oriented Stocks in Focus
Negotiations on a comprehensive India-EU trade pact are nearing completion, signaling potential tariff reductions and expanded market access for Indian exporters, particularly in pharma, IT, and specialty chemicals.
Low impactLong-term
Cipla Stock: US Arm Gets One USFDA Observation at New York Facility
Cipla's US subsidiary received a single observation after a USFDA inspection of its New York manufacturing facility, a mild compliance flag investors will watch for a response before it escalates.
Low impactShort-term
Alkem Laboratories Completes Occlutech Acquisition, Expanding Specialty Pharma Portfolio
Alkem Laboratories finalizes acquisition of Occlutech Holding AG, strengthening its presence in specialty pharmaceutical segments.
Medium impactLong-term
Poly Medicure Stock: Company Plans New Facilities to Double International Business
Poly Medicure's management says new manufacturing facilities and products should help double the company's international business.
Medium impactLong-term
Sun Pharma Wins South Africa Approval for Generic Ozempic
Sun Pharma has won approval to launch a generic version of semaglutide, sold as Ozempic and Wegovy, in South Africa.
Medium impactLong-term
Dr Reddy's Stock: Company Halts Semaglutide API Over Impurity Issue
Dr Reddy's Laboratories has halted manufacturing of the active ingredient used in its semaglutide products after an impurity was found, delaying a drug seen as a major growth driver.
Medium impactShort-term
Dr Reddy's Stock: Company Targets 6 to 7 Million Semaglutide Pens in FY27
Dr Reddy's Laboratories has set a target of producing 6 to 7 million semaglutide pens in FY27, underlining its push into the GLP-1 weight-loss and diabetes drug opportunity.
Medium impactLong-term
Zydus Lifesciences Stock: Company Seals $150 Million Sterling Biotech Deal
Zydus Lifesciences has agreed to a $150 million deal for Sterling Biotech's fermentation based manufacturing assets, adding API capacity to its pharmaceutical business.
Medium impactLong-term
Biocon Stock: Rs 1,839 Crore Block Deal Sees ICICI Pru MF, Citi, Goldman Sachs Buy In
A block deal worth Rs 1,839 crore in Biocon shares was executed, with ICICI Prudential Mutual Fund the top buyer alongside Citigroup and Goldman Sachs.
Low impactShort-term
Syngene Stock: Company Admits Missteps, Charts CDMO Turnaround Plan
Syngene International has acknowledged strategic missteps in its CDMO business and outlined a turnaround plan, signalling management wants to fix underperformance in its core contract research and manufacturing unit.
Medium impactLong-term
SPARC Stock in Focus as Anil Raghavan Named MD and CEO After Rs 1,761 Crore Turnaround
Sun Pharma Advanced Research Company (SPARC) has appointed Anil Raghavan as MD and CEO from August 11, following a reported Rs 1,761 crore financial turnaround.
Medium impactLong-term
Torrent Pharmaceuticals Recalls Semalix Injection Pens on Manufacturer Notice
Torrent Pharmaceuticals is recalling certain batches of its Semalix injection pens after a notice from the manufacturer flagged an issue with the product.
Low impactShort-term
Showing 1–16 of 50